Carlos Jiménez‐Cortegana

Myeloid-Derived Suppressor Cells and Radiotherapy

Carlos Jiménez‐Cortegana, Claudia Galassi, Vanessa Klapp et al. · Cancer Immunology Research · 2022 · 82 citations · Full text

Medicine, Immunology, Oncology +14

Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

Carlos Jiménez‐Cortegana, Natalia Palazón‐Carrión, Alejandro Martı́n et al. · Journal for ImmunoTherapy of Cancer · 2021 · 62 citations · Full text

Life Sciences, Hematology, Immunology +17

Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer

Natalia Palazón‐Carrión, Carlos Jiménez‐Cortegana, María Luisa Sánchez-León et al. · Scientific Reports · 2021 · 36 citations · Full text

Medicine, Immunology, Oncology +17

Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer

Daniel J. García-Domínguez, Soledad López, Gonzalo Álba et al. · International Journal of Molecular Sciences · 2024 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17

Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19

Carlos Jiménez‐Cortegana, Julia Liró, Natalia Palazón‐Carrión et al. · Viral Immunology · 2021 · 21 citations

Life Sciences, Immunology, Infectious Diseases +17